companiesCompany
Genesis Molecular AI (formerly Genesis Therapeutics)
Genesis Molecular AI does small-molecule discovery on its GEMS platform, which combines physics and deep learning, with oncology programmes in the clinic pipeline.
Genesis has partnerships with Genentech, Lilly, Gilead and Incyte, and rebranded in 2025.